{"id":61690,"date":"2023-12-04T11:22:57","date_gmt":"2023-12-04T02:22:57","guid":{"rendered":"https:\/\/monolith.law\/tr\/?p=61690"},"modified":"2024-03-16T16:49:34","modified_gmt":"2024-03-16T07:49:34","slug":"legal-risk-reward-orthopedic-review-contributors","status":"publish","type":"post","link":"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors","title":{"rendered":"G\u00fczellik Esteti\u011fi Yorum Sitesindeki Yorum Yapanlara \u00d6deme Yapman\u0131n Hukuki Riskleri"},"content":{"rendered":"\n<p>G\u00fczellik esteti\u011fi yorum sitelerinde, hastalardan gelen yorumlar yay\u0131nlan\u0131r.<br>Site taraf\u0131ndan, bu t\u00fcr yorumlar\u0131 g\u00f6nderen hastalara \u00f6deme yap\u0131labilir.<\/p>\n\n\n\n<p>Yorum sitelerinin yorumlar\u0131 toplamak i\u00e7in g\u00f6nderenlere \u00f6deme yapmas\u0131 yasaya ayk\u0131r\u0131 m\u0131d\u0131r? Bu eylemin sorunlar\u0131 ve dikkat edilmesi gereken noktalar\u0131 a\u00e7\u0131kl\u0131yoruz.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_53 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#Odeme_Yapmanin_Sorunlari\" title=\"\u00d6deme Yapman\u0131n Sorunlar\u0131\">\u00d6deme Yapman\u0131n Sorunlar\u0131<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#%E2%80%9CYonlendirme_Ucreti_Yasaklama_Hukmu%E2%80%9D\" title=\"&#8220;Y\u00f6nlendirme \u00dccreti Yasaklama H\u00fckm\u00fc&#8221;\">&#8220;Y\u00f6nlendirme \u00dccreti Yasaklama H\u00fckm\u00fc&#8221;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#Idari_Kurumlar_Tarafindan_Inceleme\" title=\"\u0130dari Kurumlar Taraf\u0131ndan \u0130nceleme\">\u0130dari Kurumlar Taraf\u0131ndan \u0130nceleme<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#Diger_Saglik_Siteleri_ile_Karsilastirma\" title=\"Di\u011fer Sa\u011fl\u0131k Siteleri ile Kar\u015f\u0131la\u015ft\u0131rma\">Di\u011fer Sa\u011fl\u0131k Siteleri ile Kar\u015f\u0131la\u015ft\u0131rma<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#Guzellik_Saglik_Yorumlari_Meydani%E2%80%99nin_Uygulamasi\" title=\"G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131&#8217;n\u0131n Uygulamas\u0131\">G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131&#8217;n\u0131n Uygulamas\u0131<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#Uygulamanin_Puf_Noktalari\" title=\"Uygulaman\u0131n P\u00fcf Noktalar\u0131\">Uygulaman\u0131n P\u00fcf Noktalar\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/monolith.law\/tr\/internet\/legal-risk-reward-orthopedic-review-contributors\/#Ozet\" title=\"\u00d6zet\">\u00d6zet<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Odeme_Yapmanin_Sorunlari\"><\/span>\u00d6deme Yapman\u0131n Sorunlar\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Estetik cerrahi yorum siteleri, hastalar\u0131n yorumlar\u0131na kar\u015f\u0131l\u0131k \u00f6deme yaparken, &#8216;Tedavi Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131&#8217; (Japon ~ Tedavi Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131) adl\u0131 bir kurala uymak zorundad\u0131r. Bu kurallar, asl\u0131nda, sigortal\u0131 sa\u011fl\u0131k hizmetlerini sa\u011flayan sa\u011fl\u0131k kurulu\u015flar\u0131n\u0131n uymas\u0131 gereken kurallard\u0131r. Ancak, bir sa\u011fl\u0131k kurulu\u015funun yorumlar\u0131n\u0131 tan\u0131tt\u0131\u011f\u0131n\u0131zda, yorum sitesi olarak da bu kurallara uymak zorundas\u0131n\u0131zd\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"%E2%80%9CYonlendirme_Ucreti_Yasaklama_Hukmu%E2%80%9D\"><\/span>&#8220;Y\u00f6nlendirme \u00dccreti Yasaklama H\u00fckm\u00fc&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Sigortal\u0131 Sa\u011fl\u0131k Kurulu\u015flar\u0131 ve Sigortal\u0131 Sa\u011fl\u0131k Bak\u0131m Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131 (Tedavi Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131) Madde 2, Paragraf 4, sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131n\u0131n, ekonomik faydalar sa\u011flayarak hastalar\u0131 \u00e7ekme eylemlerini yasaklar.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>Sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131, hastalara, Madde 5 h\u00fck\u00fcmlerine g\u00f6re al\u0131nan \u00fccret miktar\u0131na g\u00f6re, s\u00f6z konusu sigortal\u0131 sa\u011fl\u0131k kurulu\u015funun gelir elde eden i\u015flemleriyle ilgili mallar\u0131n bedelini indirmemeli ve sa\u011fl\u0131k sigortas\u0131 i\u015fletmecili\u011finin sa\u011fl\u0131kl\u0131 i\u015fleyi\u015fini bozabilecek ekonomik faydalar sa\u011flamamal\u0131d\u0131r. Hastalar\u0131n kendi sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131nda tedavi g\u00f6rmeleri i\u00e7in \u00e7ekici olmamal\u0131d\u0131r.<\/p>\n<cite><a href=\"https:\/\/elaws.e-gov.go.jp\/search\/elawsSearch\/elaws_search\/lsg0500\/detail?lawId=332M50000100015_20190701_501M60000100020&amp;openerCode=1\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/elaws.e-gov.go.jp\/search\/elawsSearch\/elaws_search\/lsg0500\/detail?lawId=332M50000100015_20190701_501M60000100020&amp;openerCode=1[ja]<\/a><\/cite><\/blockquote>\n\n\n\n<p>Yukar\u0131daki h\u00fck\u00fcmde, k\u0131saca, r\u00fc\u015fvetin yasakland\u0131\u011f\u0131 belirtilmi\u015ftir. Yani, hastalar ve sa\u011fl\u0131k kurulu\u015flar\u0131 aras\u0131nda, &#8220;Yorum sitesine bir yorum g\u00f6nderme kar\u015f\u0131l\u0131\u011f\u0131nda \u00fccreti azalt\u0131r\u0131z&#8221; \u015feklinde bir anla\u015fma, yasaklanan bir eylem olarak kabul edilebilir.<\/p>\n\n\n\n<p>Ayr\u0131ca, nakit yerine puan veren bir di\u015f hekimli\u011fi klini\u011fi, bu kurala ayk\u0131r\u0131 oldu\u011fu i\u00e7in sorun olmu\u015ftur, bu nedenle puan verildi\u011finde de, kural ihlali riskinin oldu\u011funu anlamak \u00f6nemlidir.<\/p>\n\n\n\n<p>Yukar\u0131daki h\u00fck\u00fcmde, &#8220;sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131&#8221; ile s\u0131n\u0131rl\u0131d\u0131r. Estetik cerrahi, sigortan\u0131n ge\u00e7erli olmad\u0131\u011f\u0131 \u00f6zg\u00fcr bir muayene oldu\u011fu i\u00e7in, estetik cerrahi hizmetleri sunan kliniklerin sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131 olmad\u0131\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnenler olabilir.<\/p>\n\n\n\n<p>Ancak, bu t\u00fcr sa\u011fl\u0131k kurulu\u015flar\u0131n\u0131n ayn\u0131 zamanda sigortal\u0131 muayene de yaparak sigortal\u0131 sa\u011fl\u0131k kurulu\u015fu olarak belirlendi\u011fi durumlar da d\u00fc\u015f\u00fcn\u00fclebilir. Ayr\u0131ca, estetik cerrahi genellikle \u00f6zel muayene olsa da, sigortal\u0131 muayene \u00fczerinde resmi bir hastal\u0131k ad\u0131 varsa ve ilgili sigortal\u0131 prosed\u00fcrler varsa, sigortal\u0131 muayene kapsam\u0131ndad\u0131r.<\/p>\n\n\n\n<p>Yukar\u0131dakileri g\u00f6z \u00f6n\u00fcnde bulundurarak, estetik cerrahi yorum sitesinin i\u015fletilmesi s\u0131ras\u0131nda, listelenen kliniklerin, Tedavi Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131n\u0131n uygulanmas\u0131n\u0131 kabul etti\u011fi varsay\u0131larak, sistem d\u00fc\u015f\u00fcn\u00fclmelidir.<\/p>\n\n\n\n<p>Yukar\u0131daki Tedavi Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131nda, yasaklanan eylemler spesifik olarak listelenmemi\u015ftir. Bu nedenle, bir eylemin yasaklan\u0131p yasaklanmad\u0131\u011f\u0131, duruma ba\u011fl\u0131 olarak belirlenir ve bir uzmana dan\u0131\u015fmak gereklidir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Idari_Kurumlar_Tarafindan_Inceleme\"><\/span>\u0130dari Kurumlar Taraf\u0131ndan \u0130nceleme<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2020\/08\/legal-risk-reward-orthopedic-review-contributors2.jpg\" alt=\"\" class=\"wp-image-16284\" \/><\/figure>\n\n\n\n<p>Sa\u011fl\u0131k merkezleri ve \u00c7al\u0131\u015fma, Sa\u011fl\u0131k ve Refah Bakanl\u0131\u011f\u0131, sa\u011fl\u0131k kurulu\u015flar\u0131n\u0131n i\u015flemlerinin sorunsuz olup olmad\u0131\u011f\u0131n\u0131 kontrol eder. Bu nedenle, sa\u011fl\u0131k kurulu\u015flar\u0131 ve yorum siteleri aras\u0131nda, hastalara r\u00fc\u015fvet verilebilece\u011fi anla\u015f\u0131lan bir anla\u015fma yapmamal\u0131s\u0131n\u0131z.<\/p>\n\n\n\n<p>Ayr\u0131ca, yorum sitesi hastalar\u0131 (g\u00f6nderenleri) toplarken, i\u015flem miktar\u0131na g\u00f6re \u00f6deme yap\u0131laca\u011f\u0131 belirtilirse, site i\u00e7inde belirtilirse, bu durumun sorunlu olabilece\u011fi olas\u0131l\u0131\u011f\u0131 y\u00fcksektir.<\/p>\n\n\n\n<p>Ancak, sa\u011fl\u0131k kurulu\u015fundan al\u0131nan \u00f6deme ve yorum sitesinden g\u00f6nderi i\u00e7in \u00f6denen \u00f6d\u00fcl aras\u0131nda bir ili\u015fki yoksa ve ayr\u0131ca i\u015flem miktar\u0131 ve \u00f6d\u00fcl miktar\u0131 aras\u0131nda bir ili\u015fki yoksa, bu ayr\u0131d\u0131r. \u00d6rne\u011fin, yorum sitesinin yorum g\u00f6nderme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6deme yapt\u0131\u011f\u0131 eylem, yorum sitesi ve hastalar aras\u0131nda tamamlanan bir anla\u015fma olarak de\u011ferlendirilebilir.<\/p>\n\n\n\n<p>Hastalar\u0131n g\u00f6nderilerini te\u015fvik etmek i\u00e7in bir \u00f6d\u00fcl sistemi uygulamak istiyorsan\u0131z, sa\u011fl\u0131k kurulu\u015funun \u00e7\u0131karlar\u0131n\u0131 korumak i\u00e7in de\u011fil, yorum sitesinin kendi \u00e7\u0131karlar\u0131 i\u00e7in \u00f6d\u00fcl verme karar\u0131 alabilecek bir mekanizma olu\u015fturman\u0131z gerekmektedir.<\/p>\n\n\n\n<p>\u00d6rne\u011fin, i\u00e7eri\u011fi zenginle\u015ftirmek ve site g\u00f6r\u00fcnt\u00fcleme say\u0131s\u0131n\u0131 art\u0131rmak i\u00e7in, yorum sitesi hastalara i\u015fi devrederek yorum g\u00f6ndermelerini sa\u011flar ve bunun kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6d\u00fcl verir. Bu durumda, Tedavi Y\u00fck\u00fcml\u00fcl\u00fck Kurallar\u0131na ayk\u0131r\u0131 olma riski d\u00fc\u015fer.<\/p>\n\n\n\n<p>Her durumda, karar vermenin zor oldu\u011fu bir durum oldu\u011fu i\u00e7in, uzman bilgisi olan bir avukata dan\u0131\u015fman\u0131z\u0131 \u00f6neririz.<\/p>\n\n\n\n<p>Ayr\u0131ca, estetik yorum sitelerinin, yorumlar\u0131 yay\u0131nlamak kar\u015f\u0131l\u0131\u011f\u0131nda hastanelerden \u00f6deme alman\u0131n hukuken sorun olup olmad\u0131\u011f\u0131na dair bir tart\u0131\u015fma noktas\u0131 da vard\u0131r.<\/p>\n\n\n\n<p>Bu konuda a\u015fa\u011f\u0131daki makalede daha ayr\u0131nt\u0131l\u0131 bir a\u00e7\u0131klama yap\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p><a href=\"https:\/\/monolith.law\/corporate\/medical-institution-reward-law\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/monolith.law\/corporate\/medical-institution-reward-law[ja]<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Diger_Saglik_Siteleri_ile_Karsilastirma\"><\/span>Di\u011fer Sa\u011fl\u0131k Siteleri ile Kar\u015f\u0131la\u015ft\u0131rma<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Sa\u011fl\u0131kla ilgili sitelerde, a\u015fa\u011f\u0131daki 3 site yorum yapanlara te\u015fekk\u00fcr ediyor.<\/p>\n\n\n\n<ul>\n<li>G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131 (<a href=\"https:\/\/clinic.e-kuchikomi.info\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/clinic.e-kuchikomi.info\/[ja]<\/a>)<\/li>\n\n\n\n<li>caloo (<a href=\"https:\/\/caloo.jp\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/caloo.jp\/[ja]<\/a>)<\/li>\n\n\n\n<li>QLIFE (<a href=\"https:\/\/www.qlife.jp\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.qlife.jp\/[ja]<\/a>)<\/li>\n<\/ul>\n\n\n\n<p>Siteler ve sa\u011fl\u0131k kurulu\u015flar\u0131 aras\u0131ndaki ili\u015fkiye gelince, hem &#8216;caloo&#8217; hem de &#8216;QLIFE&#8217; sa\u011fl\u0131k kurulu\u015flar\u0131na \u00fccretsiz kay\u0131t imkan\u0131 sunuyor. \u00d6te yandan, &#8216;G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131&#8217;nda bir ileti\u015fim formu bulunmakla birlikte, kay\u0131t \u00fccreti hakk\u0131nda herhangi bir bilgi bulunmamaktad\u0131r.<\/p>\n\n\n\n<p>Te\u015fekk\u00fcrlerin i\u00e7eri\u011fi, &#8216;caloo&#8217; ve &#8216;QLIFE&#8217; kullan\u0131c\u0131 kayd\u0131, yorum yay\u0131nlama, ziyaret bilgisi payla\u015fma vb. durumlar i\u00e7in herkese e\u015fit bir \u015fekilde belirli puanlar veriyor. Te\u015fekk\u00fcrlerin i\u00e7eri\u011fi ortak oldu\u011fu i\u00e7in, bu te\u015fekk\u00fcrlerin tedavi i\u00e7eri\u011fine uymad\u0131\u011f\u0131 a\u00e7\u0131kt\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Guzellik_Saglik_Yorumlari_Meydani%E2%80%99nin_Uygulamasi\"><\/span>G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131&#8217;n\u0131n Uygulamas\u0131<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>&#8216;G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131&#8217;, tedavi i\u00e7eri\u011fi hakk\u0131nda bilgi ald\u0131ktan sonra puanlar\u0131 belirliyor gibi g\u00f6r\u00fcn\u00fcyor. Bu nedenle, bu sitede, tedavi maliyetine ba\u011fl\u0131 olarak te\u015fekk\u00fcr miktar\u0131 de\u011fi\u015febilir.<\/p>\n\n\n\n<p>Ancak, &#8216;G\u00fczellik Sa\u011fl\u0131k Yorumlar\u0131 Meydan\u0131&#8217;nda sigortal\u0131 tedavi hakk\u0131ndaki yorumlar i\u00e7in te\u015fekk\u00fcr al\u0131namayaca\u011f\u0131na dair bir kural bulunmaktad\u0131r.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>Q10. Hangi tedaviyi al\u0131rsam alay\u0131m puan alabilir miyim?<br>A. Yorum Meydan\u0131&#8217;nda listelenen men\u00fclerden birini al\u0131rsan\u0131z, puan kar\u015f\u0131l\u0131\u011f\u0131nda nakit geri alabilirsiniz. *Sigortal\u0131 tedavi maliyetleri, t\u00fcm puan geri \u00f6deme hedeflerinin d\u0131\u015f\u0131ndad\u0131r.<br><\/p>\n<cite><a href=\"https:\/\/report.clinic\/info\/faq#open\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/report.clinic\/info\/faq#open[ja]<\/a><\/cite><\/blockquote>\n\n\n\n<p>Tekrarlamak gerekirse, tedavi y\u00f6netmeli\u011fi, sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131n\u0131n r\u00fc\u015fvet sistemini kullanmas\u0131n\u0131 yasaklar. Sigortal\u0131 bir sa\u011fl\u0131k kurulu\u015fuysan\u0131z, bile \u00f6zg\u00fcr tedavi g\u00f6ren hastalara bile ba\u015fvuru \u00fccreti \u00f6dememelisiniz. \u00d6zg\u00fcr tedavi g\u00f6ren hastalara tedavi maliyetine ba\u011fl\u0131 olarak puan sa\u011flarsan\u0131z, bu y\u00f6netmeli\u011fe ayk\u0131r\u0131 olabilir.<\/p>\n\n\n\n<p>Bu durumlar\u0131 g\u00f6z \u00f6n\u00fcnde bulundurdu\u011funda, ger\u00e7ek uygulamada, sigortal\u0131 tedavi yerine, sigortal\u0131 sa\u011fl\u0131k kurulu\u015funda al\u0131nan tedavi i\u00e7in te\u015fekk\u00fcr \u00f6demeyen farkl\u0131 bir uygulama yap\u0131l\u0131yor olabilir.<\/p>\n\n\n\n<p>Genel hastalar\u0131n, sigortal\u0131 sa\u011fl\u0131k kurulu\u015flar\u0131 ile sadece \u00f6zg\u00fcr tedavi yapan sa\u011fl\u0131k kurulu\u015flar\u0131 aras\u0131ndaki fark\u0131 anlamas\u0131 genellikle zordur. Hastalar\u0131n bilgi eksikli\u011fini g\u00f6z \u00f6n\u00fcnde bulundurarak, sigortal\u0131 tedaviye s\u0131n\u0131rl\u0131 bir \u015fekilde reddedilme ifadesi olabilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Uygulamanin_Puf_Noktalari\"><\/span>Uygulaman\u0131n P\u00fcf Noktalar\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2020\/08\/legal-risk-reward-orthopedic-review-contributors3.jpg\" alt=\"\" class=\"wp-image-16286\" \/><\/figure>\n\n\n\n<p>\u015eimdiye kadar yapt\u0131\u011f\u0131m\u0131z de\u011ferlendirmeler \u0131\u015f\u0131\u011f\u0131nda, g\u00fczellikle ilgili yorum sitelerinin inceleme kar\u015f\u0131l\u0131\u011f\u0131nda \u00f6deme yapmas\u0131 durumunda, sigortal\u0131 olmayan sa\u011fl\u0131k kurulu\u015flar\u0131nda yap\u0131lan i\u015flemler i\u00e7in sadece te\u015fekk\u00fcr \u00f6demesi yapmay\u0131 d\u00fc\u015f\u00fcnmenizi \u00f6neririz. \u00d6zetle, uygulama s\u0131ras\u0131nda a\u015fa\u011f\u0131daki iki noktaya dikkat edin.<\/p>\n\n\n\n<ol>\n<li>Hasta \u00f6d\u00fclleri, i\u015flem maliyetine kar\u015f\u0131l\u0131k gelmeyen bir sistem olmal\u0131d\u0131r<\/li>\n\n\n\n<li>Sigortal\u0131 bir sa\u011fl\u0131k kurulu\u015fuysa, sigorta d\u0131\u015f\u0131 tedavi bile tedavi y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc kurallar\u0131na tabidir<\/li>\n<\/ol>\n\n\n\n<p>Te\u015fekk\u00fcr \u00f6demesi yapma eylemi yasaklanm\u0131\u015f de\u011fildir. Ancak, tedavi y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc kurallar\u0131na ayk\u0131r\u0131 olmamak i\u00e7in, tedavi maliyetine kar\u015f\u0131l\u0131k gelmeyen bir sistem olu\u015fturman\u0131z gereklidir. Ayr\u0131ca, sigortal\u0131 bir sa\u011fl\u0131k kurulu\u015fu durumunda, sigorta d\u0131\u015f\u0131 tedavi incelemeleri de tedavi y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc kurallar\u0131n\u0131n d\u00fczenlemesine tabi oldu\u011funu l\u00fctfen unutmay\u0131n.<\/p>\n\n\n\n<p>\u0130ncelemelerin i\u00e7eri\u011fi her zaman olumlu olmayabilir. Bazen iftira ve hakaret i\u00e7eren yorumlar yap\u0131labilir. &#8220;Estetik Cerrahi Yorumlar\u0131 Forumu&#8221; g\u00f6nderilerini silmek isterseniz, l\u00fctfen bu makaleye g\u00f6z at\u0131n.<\/p>\n\n\n\n<p><a href=\"https:\/\/monolith.law\/reputation\/reviews-deletion-of-cosmetic-medicine-forum\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/monolith.law\/reputation\/reviews-deletion-of-cosmetic-medicine-forum[ja]<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ozet\"><\/span>\u00d6zet<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>G\u00fczellik esteti\u011fi inceleme sitelerinin, incelemeler kar\u015f\u0131l\u0131\u011f\u0131nda hastalara \u00f6deme yapma eyleminin hukuki risklerini \u00f6zetledik. Tart\u0131\u015fma noktas\u0131, &#8220;Japon Tedavi Y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc Y\u00f6netmeli\u011fi&#8217;nin referans \u00fccreti yasa\u011f\u0131 h\u00fckm\u00fcne ayk\u0131r\u0131 olup olmad\u0131\u011f\u0131d\u0131r.&#8221;<\/p>\n\n\n\n<p>Referans \u00fccreti yasa\u011f\u0131 h\u00fckm\u00fcnde &#8220;ilgili sigortal\u0131 sa\u011fl\u0131k kurulu\u015funun gelir elde etme i\u015flemleriyle ilgili mal\u0131n bedelini, al\u0131nan \u00fccret miktar\u0131na g\u00f6re indirmek&#8221; ifadesi bulunmaktad\u0131r. Yani, r\u00fc\u015fvet sistemi uygulan\u0131rsa, bu durumun yasa d\u0131\u015f\u0131 olma olas\u0131l\u0131\u011f\u0131 y\u00fcksektir.<\/p>\n\n\n\n<p>Y\u00f6netim, sa\u011fl\u0131k kurulu\u015flar\u0131 ve inceleme siteleri aras\u0131ndaki i\u015flem i\u00e7eri\u011fini kontrol etmek i\u00e7in, bu iki taraf aras\u0131nda, hastalara r\u00fc\u015fvet verilmesini do\u011frulayabilecek bir h\u00fck\u00fcm s\u00f6zle\u015fmeye dahil edilmemelidir.<\/p>\n\n\n\n<p>Ayr\u0131ca, hastan\u0131n alaca\u011f\u0131 tedavi i\u00e7eri\u011fi ile hastan\u0131n alaca\u011f\u0131 \u00f6d\u00fcl aras\u0131ndaki ili\u015fkiyi ortadan kald\u0131rmak da \u00f6nemlidir. Tedavi maliyetine ba\u011fl\u0131 olarak, inceleme sitesinden \u00f6d\u00fcl\u00fcn art\u0131p azalaca\u011f\u0131 bir sistem uygulamak risklidir.<\/p>\n\n\n\n<p>Uygun bir sistem olu\u015fturman\u0131n hukuk bilgisi olmadan zor olabilece\u011fi d\u00fc\u015f\u00fcn\u00fcld\u00fc\u011f\u00fcnden, bir avukata dan\u0131\u015fman\u0131z\u0131 \u00f6neririz. Monolith Hukuk B\u00fcrosu&#8217;nda, internet konusunda deneyimli avukatlar bulunmaktad\u0131r, l\u00fctfen \u00e7ekinmeden dan\u0131\u015f\u0131n.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>G\u00fczellik esteti\u011fi yorum sitelerinde, hastalardan gelen yorumlar yay\u0131nlan\u0131r.Site taraf\u0131ndan, bu t\u00fcr yorumlar\u0131 g\u00f6nderen hastalara \u00f6deme yap\u0131labilir. Yorum sitelerinin yorumlar\u0131 toplamak i\u00e7in g\u00f6nderenler [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":64007,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[21,41],"acf":[],"_links":{"self":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61690"}],"collection":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/comments?post=61690"}],"version-history":[{"count":3,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61690\/revisions"}],"predecessor-version":[{"id":64008,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61690\/revisions\/64008"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media\/64007"}],"wp:attachment":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media?parent=61690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/categories?post=61690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/tags?post=61690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}